Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00685932Not ApplicableCompleted

Mobius® Post-cesarean Pain Randomized Control Trial

Role: lead

NCT01637870Not ApplicableCompleted

Negative Pressure Wound Therapy After Cesarean Delivery

Role: lead

NCT02716636Not ApplicableCompleted

Fast Versus Slow Tenaculum Placement

Role: lead

All 3 trials loaded